Tissue-specific transcriptional regulation is central to human disease 1 . To identify regulatory DNA active in human pancreatic islets, we profiled chromatin by formaldehyde-assisted isolation of regulatory elements 2-4 coupled with high-throughput sequencing (FAIRE-seq). We identified ~80,000 open chromatin sites. Comparison of FAIRE-seq data from islets to that from five non-islet cell lines revealed ~3,300 physically linked clusters of islet-selective open chromatin sites, which typically encompassed single genes that have islet-specific expression. We mapped sequence variants to open chromatin sites and found that rs7903146, a TCF7L2 intronic variant strongly associated with type 2 diabetes 5 , is located in islet-selective open chromatin. We found that human islet samples heterozygous for rs7903146 showed allelic imbalance in islet FAIRE signals and that the variant alters enhancer activity, indicating that genetic variation at this locus acts in cis with local chromatin and regulatory changes. These findings illuminate the tissue-specific organization of cis-regulatory elements and show that FAIRE-seq can guide the identification of regulatory variants underlying disease susceptibility.
Tissue-specific transcriptional regulation is central to human disease 1 . To identify regulatory DNA active in human pancreatic islets, we profiled chromatin by formaldehyde-assisted isolation of regulatory elements 2-4 coupled with high-throughput sequencing (FAIRE-seq). We identified ~80,000 open chromatin sites. Comparison of FAIRE-seq data from islets to that from five non-islet cell lines revealed ~3,300 physically linked clusters of islet-selective open chromatin sites, which typically encompassed single genes that have islet-specific expression. We mapped sequence variants to open chromatin sites and found that rs7903146, a TCF7L2 intronic variant strongly associated with type 2 diabetes 5 , is located in islet-selective open chromatin. We found that human islet samples heterozygous for rs7903146 showed allelic imbalance in islet FAIRE signals and that the variant alters enhancer activity, indicating that genetic variation at this locus acts in cis with local chromatin and regulatory changes. These findings illuminate the tissue-specific organization of cis-regulatory elements and show that FAIRE-seq can guide the identification of regulatory variants underlying disease susceptibility.
Pancreatic islets are composed of endocrine cells that secrete insulin, glucagon and other polypeptide hormones. Islet cells are essential for glucose homeostasis, and thus explaining the transcriptional control of islet-cell function and growth has implications for understanding diabetes pathogenesis and treatment 6, 7 . Gene regulatory elements often function by recruiting DNA-associated proteins to specific loci, a process that typically results in local nucleosome eviction 8 . Nucleosome loss, or formation of 'open chromatin' , is an evolutionarily conserved indicator of regulatory activity and can be used as a molecular tag to isolate regions of the genome bound by regulatory factors 9 .
For three samples of purified human pancreatic islets, we used FAIRE 2-4 to identify sites of open chromatin (Fig. 1a , Table 1 and Supplementary  Table 1 ). We technically validated the FAIRE-seq data by showing its high concordance to patterns determined by hybridization of the same FAIRE samples to tiling DNA microarrays ( Fig. 1b and Supplementary Fig. 1) . Further, we found that despite differences in an individual's age, cause of death or genotype and variations in islet isolation procedures and levels of exocrine cell contaminants, the majority of regions identified by FAIRE in any one sample were also detected in the others (Supplementary Fig. 1b) . Thus, FAIRE-seq is a robust method for characterizing chromatin in islets.
Several lines of evidence indicate that FAIRE reliably identifies active regulatory elements in islets. Consistent with FAIRE results in fibroblasts 2 , the most enriched FAIRE regions were found near known transcription start sites (TSSs) ( Fig. 2a) l e t t e r s relationship between FAIRE signals near TSSs and transcript levels in human islets 10 ( Fig. 2a) . Further, promoters previously shown to bind RNA polymerase II and the transcription factors HNF4A or HNF1A in islets 11 were enriched by FAIRE more frequently than other promoter regions ( Fig. 2b) .
To extend this observation, we identified regulatory regions that were used selectively in islets relative to other cell types. We compared FAIRE-seq data from islets to data from five non-islet cell lines (HeLa-S3, HUVEC, GM12878, HepG2 and K562; Online Methods) and found that 45% of islet open chromatin sites were unique to islets among this group of cell types. We refer to these sites as isletselective open chromatin. We identified 340 genes from the NCBI RefSeq database with islet-selective open chromatin in the TSS or gene body (Supplementary Table 2 ). This relatively short list included 24 well-characterized genes that are selectively expressed in islets ( Supplementary Table 3 ), including genes involved in human diabetes (PDX1, ABCC8, SLC30A8, G6PC2 and GAD2) and genes that encode islet developmental regulators (NEUROD1, NKX6-1, PAX6 and ISL1) 6, 7, [12] [13] [14] . Therefore, islet-selective open chromatin detected by FAIRE identified loci integral to islet-cell biology and disease.
Many sites of open chromatin detected by FAIRE are located in intergenic regions, far (>2 kb) from a known TSS. For these distal sites, evidence also points strongly toward a regulatory function. First, distal intergenic open chromatin sites were enriched in evolutionarily conserved sequences, in predicted transcription factor binding sites and in regulatory modules, regardless of whether the open chromatin was islet selective or ubiquitous (that is, shared by all six cell types) ( Fig. 2c, Supplementary Fig. 1d , Supplementary Table 4 and Online Methods). Second, ubiquitous intergenic open chromatin coincided more often than would be expected by chance (observed coincidence, 16%; expected coincidence, 0.39%; P < 0.001; Fig. 2c ) with binding sites for CTCF [15] [16] [17] , a transcriptional regulator and insulator protein that binds to a large number of genomic sites, many of which are shared in different cell types 16 . Open chromatin at CTCF sites was centered at the locations of CTCF binding 15 , suggesting that FAIRE signal is indicative of interactions between regulatory factors and DNA (Fig. 2d) . Third, intergenic islet-selective (but not ubiquitous) open chromatin preferentially harbors DNA-binding motifs of pancreatic islet transcription factors, including RFX, TCF1 (also known as HNF1), HNF3B, FOXD and MAF (P < 0.01; Supplementary  Table 4 ). Notably, whereas ~36% of ubiquitous open chromatin was located within the region spanning to 2 kb upstream of a TSS or in the first exon of the gene, only 1% of islet-selective open chromatin was located in these regions ( Fig. 2e) . Collectively, these findings indicate that distal FAIRE sites harbor regulatory elements and, consistent with recent studies of histone modification patterns in enhancer regions 18 , suggest that most cell-type-specific open chromatin is located far from known TSSs.
We next sought to link these distal islet-selective elements to specific genes. We examined whether islet-selective sites showed a higher-order organization that could point to the existence of functional domains. We found that open chromatin sites were not evenly distributed throughout the genome but were instead located in physically linked clusters ( Fig. 3a) . Clustering was also observed with islet-selective open chromatin ( Fig. 3b) . We identified 3,348 domains containing at least three islet-selective open chromatin sites separated by less than 20 kb, which we referred to as islet-selective clusters of open regulatory elements (COREs) ( Fig. 3c , Supplementary Table 5 and Online Methods). Islet-selective COREs had a median size of 25 kb, with the largest islet-selective CORE containing 148 FAIRE l e t t e r s sites spanning 602 kb ( Fig. 3d) . Consistent with the fact that CTCF binds to insulator elements that separate chromatin domains 19 , the frequency of CTCF binding sites was twofold higher outside COREs than within them (P = 1.3 × 10 −48 ). This suggested that islet-selective COREs are functional chromatin domains and provided an avenue to assign open chromatin sites to genes. Sixty-nine percent of islet-selective COREs were located within 10 kb of at least one RefSeq gene (54% in randomized COREs; P = 1.5 × 10 −35 , Fig. 3e ). Of these COREs, 94% were associated with only one gene, and most were contained within 2 kb of gene boundaries ( Supplementary Fig. 2 ), suggesting that they had single-gene regulatory function (expected proportion associated with only one gene = 84%; P = 6.2 × 10 −23 , Fig. 3e and Online Methods). Genes overlapping islet COREs had higher expression in islets and in brain tissue compared to other primary tissues (one-way ANOVA, both tissues P < 1 × 10 −5 ; Fig. 3f ), consistent with the neuroendocrine nature of islet cells 20 . Islet-selective COREs were also enriched in genes linked to isletspecific functions, including those encoding transcription factors, ion channels and secretory apparatus components ( Table 2 and Supplementary Table 6 ). Thus, islet-selective COREs are typically linked to single genes that are expressed in an islet-selective manner.
A subset of islet-selective COREs spanned notably broad distances at loci containing genes that encode critical regulators of pancreas development and function ( Fig. 3g , Supplementary Table 7 and Supplementary Figs. 2 and 3) . For example, an islet-selective CORE spanned a 46-kb domain containing PDX1, a master regulator of pancreas development and β-cell function 7 (Fig. 3g) . At this locus, FAIRE sites coincided with previously characterized evolutionarily conserved enhancers named 'area I-IV' 21, 22 and with uncharacterized putative enhancer sites ( Fig. 3g) . Other islet-selective COREs included a 94-kb domain 3′ of NKX6-1, an essential regulator of β-cell differentiation 23 ; one CORE located in a cluster of brain-enriched small nucleolar RNA (snoRNA) and microRNAs (miRNAs) 24 and another located in conserved sequences >400 kb from any annotated gene (see Supplementary  Fig. 3 and Supplementary Table 7 for additional examples). Such domains contrasted with other loci devoid of open chromatin and known to be inactive in islets ( Supplementary Fig. 3q-s The seven most enriched Gene Ontology (GO) and PANTHER biological process terms are listed. A more comprehensive list is shown in supplementary table 6.
l e t t e r s
Recent genome-wide association studies for type 2 diabetes (T2D) susceptibility have implicated sequence variants at multiple loci, many of which may impair islet-cell function 13, 14, [25] [26] [27] . Many T2D susceptibility loci do not contain strongly associated variants in protein-coding regions, suggesting that the underlying functional variants regulate gene activity. Further, at each locus, most associated SNPs are not expected to directly affect disease risk and are instead in linkage disequilibrium with one or more functional variant(s). We sought to use our open chromatin map to guide identification of functional regulatory SNPs. We identified known SNPs mapping to islet FAIRE sites and focused on 20 loci harboring variants associated with T2D or fasting glycemia 5, 13, 14, 25, 28 (Fig. 4a and Supplementary  Table 8 ). Of 350 SNPs in strong linkage disequilibrium with a reported SNP associated with T2D or fasting glycemia (Online Methods), 38 SNPs at 10 loci overlapped islet FAIRE regions ( Fig. 4a and Supplementary Table 8 ). Notably, rs7903146 in TCF7L2, which shows consistent T2D association in samples across diverse ethnic groups 29 , is located in an islet-selective open chromatin site ( Fig. 4b  and Supplementary Fig. 4a) .
The presence of rs7903146 in a FAIRE-enriched site allowed us to test directly whether sequence variation at this locus correlates with chromatin state in islet cells. We tested 31 human islet samples and identified 9 individuals heterozygous at rs7903146. Using two independent assays, FAIRE-isolated DNA from heterozygous individuals exhibited a T:C allelic ratio that was significantly greater than observed from input genomic DNA or from genomic DNA from unrelated heterozygote individuals (real-time PCR: input, T allele 49.3 ± 1.0%; FAIRE: T allele 57.3 ± 2.8 %, P = 2.1 × 10 −5 ; Fig. 4c ; quantitative sequencing: input, T allele 57.5 ± 2.7%; FAIRE: T allele 66.2 ± 4.6%, P = 0.004; Fig. 4d and Supplementary Fig. 4b) . Thus, in human islet cells, the chromatin state at rs7903146 is more open in chromosomes carrying the T allele, which is associated with increased risk of T2D 5 .
Next, we created allele-specific luciferase reporter constructs and measured enhancer activity in two islet β-cell lines, MIN6 and 832/13. We observed allelic differences in enhancer activity in both cell lines. The T allele showed significantly greater enhancer activity than the C allele in both orientations (forward: MIN6 P = 1.6 × 10 −7 , 832/13 P = 0.005; reverse: MIN6 P = 3.1 × 10 −7 , 832/13 P = 3.1 × 10 −4 ; Fig. 4e,f and Supplementary Fig. 4c,d) . However, allele-specific differences were not observed in the human embryonic kidney cell line 293T (Supplementary Fig. 4e) . These data suggest that sequence variation 
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T T T C l e t t e r s at TCF7L2 affects T2D susceptibility by altering cis regulation and local chromatin structure in islet cells. The results are consistent with a previous report of association between the T allele and increased TCF7L2 transcripts in islets 29 , although the allele-specific changes described here can potentially effect different genomic regulatory functions, including transcriptional rates, promoter usage or splicing.
To our knowledge, this study presents the first high-resolution atlas of regulatory elements in pancreatic islets. The unbiased maps generated by FAIRE-seq provide new insights regarding the organization of tissue-specific cis-regulatory elements. Many earlier studies have shown that the genome is functionally organized in chromosomal territories 1, [30] [31] [32] . Our observations extend previous findings by uncovering the existence of a large number of cell-selective regulatory domains associated with single genes, and we provide a foundation for a mechanistic understanding of the transcriptional regulation of genes important for pancreatic islet cells. Identification of regulatory sites in a disease-relevant primary tissue also serves to greatly reduce the genomic space when searching for functional noncoding sequence variants that influence T2D susceptibility. More generally, the current study provides a framework to move forward from the identification of large sets of disease-associated variants toward understanding the subset of functional variants that underlie disease risk.
METhoDs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. Accession codes. Human islet FAIRE-seq raw data, alignments in the form of mean-centered base counts, and enriched sites at the three thresholds for all three samples can be obtained from Gene Expression Omnibus (GSE17616). Microarray data generated by hybridization of islet FAIRE preparations can also be obtained from Gene Expression Omnibus (GSE17616).
oNLINE METhoDs
Islet sample preparation. All experiments were performed according to protocols approved by the Institutional ethical committees of the Hospital Clinic de Barcelona, Geneva University Hospitals, Istituto Scientifico Ospedale San Raffaele and Hospital Universitari de Bellvitge. All samples were isolated from multiorgan donors without a history of glucose intolerance after informed consent was obtained from family members. Information on samples used for FAIRE-seq are provided in Supplementary Table 1 . Pancreatic islets were isolated according to established procedures 33 . After isolation, islets were cultured in CMRL 1066 medium containing 10% FCS serum and shipped at room temperature in the same medium. Samples 1 and 2 were processed upon arrival, whereas sample 3 and subsequent samples used in locus-specific assays were recultured in RPMI 1640 medium containing 10% FCS for 3 d before performing FAIRE. Islets were rinsed with PBS buffer 3 times and cross-linked for 10 min in 1% formaldehyde at room temperature with constant shaking. After adding glycine (final concentration 125 mM), islets were rinsed with PBS-containing protease inhibitor cocktail (Roche) at 4 °C, snap frozen and stored at −80 °C. Islet purity was assessed by dithizone staining 34 immediately before fixation. The accuracy of dithizone staining was verified by immunofluorescence analysis using DAPI fluorescent stain, anti-insulin and anti-glucagon antibodies 35 .
FAIRE. For all but two samples (see below)
, FAIRE was performed as described 2 with modifications. Frozen pellets with ~3,000 cross-linked islets were thawed on ice in 1 ml lysis buffer (2% Triton X-100, 1% SDS buffer, 100 mM NaCl, 10 mM Tris-Cl at pH 8.0 and 1 mM EDTA buffer) and disrupted with five 1-min cycles using 0.5-mm glass beads (BioSpec). Samples were sonicated for 10-20 rounds of 30 pulses each (1 s on and 0.5 s off) using a Branson Sonifier 450D at 15% amplitude. After 10 rounds, the efficiency of sonication was assessed, and further rounds were performed when needed to ensure that the majority of chromatin fragments were in the 200-1,000-bp range. Debris was cleared by centrifugation at 15,000g for 5 min at 4 °C. Nucleosome-depleted DNA was extracted with phenol-chloroform followed by ethanol precipitation and RNase A (100 µg/ml) treatment 2 .
For samples 1 and 2, we used a modified procedure that yielded less consistent chromatin fragmentation. Cells were incubated with the following buffers: 50 mM HEPES (pH 8.0), 140 mM NaCl, 1 mM EDTA, 0.1% SDS and 0.1% sodium deoxycholate, then centrifuged at 9,000g for 10 min. The pellet was resuspended in 50 mM HEPES (pH 8.0), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS and 0.1% sodium deoxycholate and then processed as described above.
Sequence analysis. Libraries were generated from gel-purified ~200-bp DNA fragments. After adaptor ligation and PCR-based amplification, samples were sequenced on the Illumina Genome Analyzer II platform using standard procedures. Sequence reads were aligned to the human reference genome (hg18) using mapping and assembly with qualities (MAQ) with default mapping parameters 36 . Post-alignment processing removed all reads that had an overall MAQ mapping quality <30 and artificially extended each read to a final length of 200 bp. We counted filtered reads mapping to each base in the genome to obtain a read density for each base. To facilitate display, read densities were centered on the mean read density of each chromosome.
Sites of FAIRE-seq enrichment were assessed with F-seq 37 , which uses a kernel density estimate to calculate genomic regions where the continuous probability is greater than a user-defined standard deviation (s.d.) threshold over the mean across a local background. We used a feature length of 1,000 bp and three standard deviation thresholds, resulting in three sets of enriched regions for each sample. The most liberal threshold was set for each sample using an empirical estimation of the upper bounds on the number of nucleosomedepleted regions genome-wide (roughly 200,000). For sample 3, the thresholds used were s.d. = 6 (liberal), s.d. = 8 (moderate) and s.d. = 10 (stringent). For samples 1 and 2, which were sequenced to a lower depth, the thresholds used were s.d. = 4 (liberal), s.d. = 5 (moderate) and s.d. = 8 (stringent).
We estimated the mappable proportion of the reference genome in two ways, using 120 million randomly generated reads (2.7 × 10 9 mappable bases, ~85% of hg18) and using PeakSeq (2.8 × 10 9 mappable bases, ~89% of hg18) 38 . We independently calculated genome coverage using 125 million reads obtained from islet FAIRE and found the coverage to be 97.9% and 97.7% concordant, respectively.
Sequence reads obtained from five major ENCODE cell lines (GM12878, HeLa-S3, HUVEC, K562 and HepG2) were aligned to the reference genome (hg18) using MAQ 36 and filtered as described above. Sites of enrichment were determined using F-seq 37 , using the same parameters as islet samples 1 and 2.
Microarray analysis. Islet FAIRE preparations from samples 1 and 2 were fluorescently labeled and hybridized to a tiling DNA microarray covering 1% of the genome selected for the ENCODE pilot project 1 . Sites of enrichment were called using ChIPOTle 39 . For receiver operating characteristic curve analysis, sites of enrichment were called using a P-value threshold of 1 × 10 −12 .
Regulatory feature analysis. We recorded the percentage of bases underlying FAIRE-seq sites that overlapped 28-species conserved elements 40 , predicted regulatory modules (PreMod) 41 and transcription factor binding sites (TRANSFAC 42 and MotifMap 43 ). For each set of peaks, we permuted positions across the mappable genome 1,000 times and recalculated the overlap. P values were calculated from permutations that had a higher degree of overlap than the observed set of peaks. We used Clover (see URLs) to test for overrepresented transcription factor binding motifs in sequences underlying intergenic FAIRE-seq enrichment 44 . Sequences were separated by chromosome and analyzed for motifs from JASPAR 45 and TRANSFAC 42 , as well as the CTCF motif 15 . Significance was calculated by comparing to the mappable intergenic portion of the tested chromosome, and motifs reaching a P-value threshold of 0.01 were reported.
FAIRE-seq and expression level analysis.
We used robust multichip average (RMA)-normalized signals from a previously reported experiment using Affymetrix Human Genome-U133A and Human Genome-U133B GeneChips with five nondiabetic islet samples 10 and obtained an average value for each probe. The five samples were selected by hierarchically clustering expression data from seven nondiabetic individuals. We excluded two samples (Sydp2 and SydPI) that had poor concordance with the others and showed low expression of known islet genes. We counted the number of FAIRE-seq reads mapping to each base in a 1-kb window surrounding each RefSeq TSS, grouped RefSeq genes by their average islet expression level and, for each group, calculated the average mean-centered FAIRE read density at every base in the window.
Islet-selective and ubiquitous site definitions. An islet FAIRE-seq site was considered 'islet selective' if the site did not overlap a site from any of the five additional tested cell types. Note that such sites are not expected to be necessarily unique to islets. An islet site was considered 'ubiquitous' if the site overlapped a FAIRE-seq site in all five additional cell types. Moderate stringency FAIRE-seq site thresholds were used for all datasets.
Selection of genes with islet-selective open chromatin.
For each RefSeq transcript, we assessed the region ranging from 2-kb upstream to 2-kb downstream and calculated the percentage of bases that overlapped a moderate islet FAIRE enrichment site. We calculated the same value in the combined data from five non-islet cell lines and selected genes that were more or equally enriched in islets compared to combined non-islet data.
Clusters of open regulatory elements (COREs).
Using Galaxy 46 , we identified 3,348 regions with at least three islet-selective sites (as defined above) located <20 kb from each other. These criteria were based on the typical size of isletselective clusters (Fig. 3b) . For comparisons, we created a set of randomized COREs of identical size and mappability. To assess CTCF binding enrichment, we obtained CTCF binding sites from multiple cell types 17 , calculated their frequency within all islet-selective COREs (0.007 sites per kb), in randomized COREs (0.013 sites per kb) and in the mappable genome (0.013 sites per kb) and tested for significance using a two-sided χ 2 test.
RefSeq, noncoding RNA or non-RefSeq Unigene transcripts were assigned to a CORE when the transcriptional start or end site was within 10 kb of either end of the CORE. When comparing CORE overlaps with one or more genes, we required a minimum overlap of one bp. We used DAVID 47 to test enrichment of biological processes in CORE genes and used all RefSeq genes as a background. We used all biological processes from Gene Ontology (GO; see URLs) and PANTHER 48 , removing GO terms associated with >1,000 genes from the analysis.
For gene expression comparisons, we obtained GCRMA-normalized signals from Affymetrix Human Genome U133A and GNF1H microarrays from seven tissues (pancreatic islet, liver, heart, kidney, lung, skeletal muscle and whole brain) 49 . We required that probes report a signal of >100 in at least one tissue. We used one-way ANOVA to assess expression differences between tissues for CORE genes and for an identical number of randomly selected genes that did not overlap a CORE gene.
Definition of T2D susceptibility variants. We identified 20 loci at which SNPs have been reported to show genome-wide association (P < 5 × 10 −8 ) with T2D or fasting glycemia 14, 25, 26, [50] [51] [52] [53] [54] . For each locus, we identified variants in HapMap CEU release 22 in strong linkage disequilibrium (r 2 > 0.8) with the reported reference SNP; 350 variants satisfied these criteria and were termed 'T2D-associated SNPs'. We then defined the region of association for each locus by manually identifying recombination hotspots from HapMap release 22 data flanking the associated SNPs. We identified SNPs in the NCBI dbSNP database v129 with an average heterozygosity >1% in these regions. SNPs that overlapped FAIRE sites in sample 3 were recorded.
Detection of allelic imbalance in open chromatin and PCR analysis of FAIRE.
We genotyped 31 human islet gDNA samples using TaqMan SNP Genotyping Assays (Applied Biosystems). Nine samples were heterozygous for rs7903146. For these samples, we used TaqMan SNP Genotyping Assays to determine the allelic ratio of DNA fragments containing rs7903146 in FAIRE compared to input DNA. All reactions were performed in triplicate in a volume of 25 µl using 5 ng DNA quantified with a Nanodrop 1000 (Thermo Scientific). A standard curve was generated by mixing gDNA from samples with known genotypes to generate seven allelic ratios: 10:90, 20:80, 40:60, 50:50, 60:40, 80:20 and 90:10. The relative abundance of T and C alleles in each experimental sample was estimated from the standard curve and was compared to input DNA from the same samples and gDNA from unrelated heterozygous individuals. Allelic ratio was also assessed in seven samples heterozygous for rs7903146 by quantitative Sanger sequencing in FAIRE and input DNA (oligonucleotides shown in Supplementary Table 9 ). ImageJ (see URLs) was used to quantify the area under the curve of the peaks in the chromatogram. Data are expressed as mean ± s.d. and were assessed with two-sided unpaired t-tests for gDNA compared to FAIRE or as paired t-tests for input compared to FAIRE.
To confirm islet-selective FAIRE enrichments, we used real-time PCR with SYBR Green dye detection as described 55, 56 . We performed triplicate measurements from 5 ng FAIRE DNA and used a serial dilution of input DNA as the standard curve. We expressed FAIRE enrichment values relative to the enrichment values in the same sample at a local negative control region.
Luciferase reporter assays.
A 240-bp fragment surrounding rs7903146 was PCR-amplified from DNA of individuals homozygous for either the T or C allele of rs7903146 (oligonucleotides shown in Supplementary Table 9 ). PCR fragments were cloned in both orientations in the multiple cloning site of the minimal promoter-containing firefly luciferase reporter vector pGL4.23 (Promega). Four independent clones for each allele for each orientation were verified by sequencing and transfected in duplicate into MIN6 (ref. 57) and 832/13 cell lines (C. Newgard, Duke Univ.), β-cell lines and HEK293T cells. Cells were cotransfected with a phRL-TK Renilla luciferase vector to control for transfection efficiency. Transfections were performed with Lipofectamine 2000 (for MIN6 and HEK 293T; Invitrogen) or FUGENE-6 (for 832/13; Roche Diagnostics). Cells were assayed 48 h after transfection using the Dual-Luciferase Assay (Promega). Firefly luciferase activity was normalized to Renilla luciferase activity and then divided by values for a pGL4.23 minimal promoter empty vector control. A two-sided t-test was used to compare luciferase activity between alleles. Experiments in MIN6 and 832/13 cells were carried out on a second independent day and yielded comparable allele-specific results.
URLs. GO, http://www.geneontology.org/; ImageJ, http://rsbweb.nih.gov/ij/; Clover, http://zlab.bu.edu/clover/.
